A Content Assessment Tool for the exhibit design process, using graphic design and communication theory as a framework for generating meaningful messages.

Current museum exhibit design models take designers through stages of defining goals, developing products or exhibits, and implementing the design. The models are intended for a staff of various experts who are expected to use their talents in creating an effective, meaningful exhibit that conveys a particular message. In many cases however, a single curator whose expertise is not in the field of design or visual communication, is given the task of designing exhibits. Curators may or may not have a few staff members or volunteers to help in the design process, but the lack of graphic design or visual communication expertise leaves out much of the know-how necessary in order to develop an intended message of an exhibit. This thesis proposes a Content Assessment Tool (CAT) that can be used as a tool to implement communication theory into the exhibit design process. The CAT was created by using Berlo\u27s communication model (Source, Message, Channel, and Receiver) as a framework that was then elaborated on to accommodate the instructional, graphic, narrative and interactive components that all go into exhibit design. To understand how the CAT can work as an evaluation tool and to demonstrate the necessity of such a tool, four small Iowa history museum curators were interviewed about each museum\u27s design process. Exhibits from each museum were photo-documented and two from each museum were then selected to be evaluate with the Content Assessment Tool. The findings revealed a significant weakness for museums in the development of exhibit graphics in generating and enhancing an intended message. All museums, even museums with experts on staff, that wish to enhance or strengthen the narrative of exhibits could benefit from such an addition as the CAT within their design process

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.

Paclitaxel is a common chemotherapy drug associated with the development of chronic paclitaxel-induced peripheral neuropathy (PIPN). PIPN is associated with neuroinflammatory mechanisms in pre-clinical studies. Here, we evaluated for differential gene expression (DGE) in peripheral blood between breast cancer survivors with and without PIPN and for neuroinflammatory (NI) related signaling pathways and whole-transcriptome profiles from other experiments. Pathway impact analysis identified 8 perturbed NI related pathways. Expression profile analysis found 15 experiments having similar whole-transcriptome profiles of DGE related to neuroinflammation and PIPN. These findings suggest that perturbations in pathways associated with neuroinflammation are found in cancer survivors with PIPN

A Riboswitch-Based Inducible Gene Expression System for Mycobacteria

Research on the human pathogen Mycobacterium tuberculosis (Mtb) would benefit from novel tools for regulated gene expression. Here we describe the characterization and application of a synthetic riboswitch-based system, which comprises a mycobacterial promoter for transcriptional control and a riboswitch for translational control. The system was used to induce and repress heterologous protein overexpression reversibly, to create a conditional gene knockdown, and to control gene expression in a macrophage infection model. Unlike existing systems for controlling gene expression in Mtb, the riboswitch does not require the co-expression of any accessory proteins: all of the regulatory machinery is encoded by a short DNA segment directly upstream of the target gene. The inducible riboswitch platform has the potential to be a powerful general strategy for creating customized gene regulation systems in Mtb

Upper extremity impairments in women with or without lymphedema following breast cancer treatment

Breast-cancer-related lymphedema affects ∼25% of breast cancer (BC) survivors and may impact use of the upper limb during activity. The purpose of this study is to compare upper extremity (UE) impairment and activity between women with and without lymphedema after BC treatment. 144 women post BC treatment completed demographic, symptom, and Disability of Arm-Shoulder-Hand (DASH) questionnaires. Objective measures included Purdue pegboard, finger-tapper, Semmes-Weinstein monofilaments, vibration perception threshold, strength, range of motion (ROM), and volume. Women with lymphedema had more lymph nodes removed (p < .001), more UE symptoms (p < .001), higher BMI (p = .041), and higher DASH scores (greater limitation) (p < .001). For all participants there was less strength (elbow flexion, wrist flexion, grip), less shoulder ROM, and decreased sensation at the medial upper arm (p < .05) in the affected UE. These differences were greater in women with lymphedema, particularly in shoulder abduction ROM (p < .05). Women with lymphedema had bilaterally less elbow flexion strength and shoulder ROM (p < .05). Past diagnosis of lymphedema, grip strength, shoulder abduction ROM, and number of comorbidities contributed to the variance in DASH scores (R 2 of 0.463, p < .001). UE impairments are found in women following treatment for BC. Women with lymphedema have greater UE impairment and limitation in activities than women without. Many of these impairments are amenable to prevention measures or treatment, so early detection by health care providers is essential

Mechanosensitivity during lower extremity neurodynamic testing is diminished in individuals with Type 2 Diabetes Mellitus and peripheral neuropathy: a cross sectional study

<p>Abstract</p> <p>Background</p> <p>Type 2 Diabetes Mellitus (T2DM) and diabetic symmetrical polyneuropathy (DSP) impact multiple modalities of sensation including light touch, temperature, position sense and vibration perception. No study to date has examined the mechanosensitivity of peripheral nerves during limb movement in this population. The objective was to determine the unique effects T2DM and DSP have on nerve mechanosensitivity in the lower extremity.</p> <p>Methods</p> <p>This cross-sectional study included 43 people with T2DM. Straight leg raise neurodynamic tests were performed with ankle plantar flexion (PF/SLR) and dorsiflexion (DF/SLR). Hip flexion range of motion (ROM), lower extremity muscle activity and symptom profile, intensity and location were measured at rest, first onset of symptoms (P1) and maximally tolerated symptoms (P2).</p> <p>Results</p> <p>The addition of ankle dorsiflexion during SLR testing reduced the hip flexion ROM by 4.3° ± 6.5° at P1 and by 5.4° ± 4.9° at P2. Individuals in the T2DM group with signs of severe DSP (n = 9) had no difference in hip flexion ROM between PF/SLR and DF/SLR at P1 (1.4° ± 4.2°; paired t-test p = 0.34) or P2 (0.9° ± 2.5°; paired t-test p = 0.31). Movement induced muscle activity was absent during SLR with the exception of the tibialis anterior during DF/SLR testing. Increases in symptom intensity during SLR testing were similar for both PF/SLR and DF/SLR. The addition of ankle dorsiflexion induced more frequent posterior leg symptoms when taken to P2.</p> <p>Conclusions</p> <p>Consistent with previous recommendations in the literature, P1 is an appropriate test end point for SLR neurodynamic testing in people with T2DM. However, our findings suggest that people with T2DM and severe DSP have limited responses to SLR neurodynamic testing, and thus may be at risk for harm from nerve overstretch and the information gathered will be of limited clinical value.</p

A Content Assessment Tool for the exhibit design process, using graphic design and communication theory as a framework for generating meaningful messages.

Current museum exhibit design models take designers through stages of defining goals, developing products or exhibits, and implementing the design. The models are intended for a staff of various experts who are expected to use their talents in creating an effective, meaningful exhibit that conveys a particular message. In many cases however, a single curator whose expertise is not in the field of design or visual communication, is given the task of designing exhibits. Curators may or may not have a few staff members or volunteers to help in the design process, but the lack of graphic design or visual communication expertise leaves out much of the know-how necessary in order to develop an intended message of an exhibit. This thesis proposes a Content Assessment Tool (CAT) that can be used as a tool to implement communication theory into the exhibit design process. The CAT was created by using Berlo's communication model (Source, Message, Channel, and Receiver) as a framework that was then elaborated on to accommodate the instructional, graphic, narrative and interactive components that all go into exhibit design. To understand how the CAT can work as an evaluation tool and to demonstrate the necessity of such a tool, four small Iowa history museum curators were interviewed about each museum's design process. Exhibits from each museum were photo-documented and two from each museum were then selected to be evaluate with the Content Assessment Tool. The findings revealed a significant weakness for museums in the development of exhibit graphics in generating and enhancing an intended message. All museums, even museums with experts on staff, that wish to enhance or strengthen the narrative of exhibits could benefit from such an addition as the CAT within their design process.</p

Impact of movement sequencing on sciatic and tibial nerve strain and excursion during the straight leg raise test in embalmed cadavers

STUDY DESIGN: Laboratory study, repeated-measures design. OBJECTIVES: To quantify differences in sciatic and tibial nerve biomechanics (strain and excursion) during common variations of the straight leg raise (SLR) test. BACKGROUND: Hip flexion and ankle dorsiflexion are the primary movement components of the SLR. It has been suggested that the nervous system is loaded differently when ankle dorsiflexion is added before or after hip flexion. There are, however, no data to either support or refute this suggestion. METHODS: Strain and excursion in the sciatic and tibial nerve were measured in the hip, knee, and ankle regions during 2 movement sequences for the SLR test in 10 embalmed cadavers. The proximal-to-distal sequence consisted of hip flexion followed by ankle dorsiflexion; the distal-to-proximal sequence consisted of ankle dorsiflexion followed by hip flexion. RESULTS: In the SLR end position, strain and excursion were comparable for both sequences for the sciatic and tibial nerve at the knee (P>.24). Strain in the tibial nerve at the ankle was greater with the proximal-to-distal sequence (P = .008), but the actual difference was small (0.8%). The pattern of strain increase and nerve excursion varied between sequences (P≤.009), with nerve strain increasing earlier and being maintained longer in regions closest to the joint that was moved first in the movement sequence. CONCLUSION: Varying the movement sequence does not substantially impact excursion and strain in the end position of the SLR. Therefore, if neurodynamic test sequencing is useful in the differential diagnosis of neuropathies, it is not likely due to differences in strain in the end position of testing

Upper extremity impairments in women with or without lymphedema following breast cancer treatment.

IntroductionBreast-cancer-related lymphedema affects approximately 25% of breast cancer (BC) survivors and may impact use of the upper limb during activity. The purpose of this study is to compare upper extremity (UE) impairment and activity between women with and without lymphedema after BC treatment.Methods144 women post BC treatment completed demographic, symptom, and Disability of Arm-Shoulder-Hand (DASH) questionnaires. Objective measures included Purdue pegboard, finger-tapper, Semmes-Weinstein monofilaments, vibration perception threshold, strength, range of motion (ROM), and volume.ResultsWomen with lymphedema had more lymph nodes removed (p &lt; .001), more UE symptoms (p &lt; .001), higher BMI (p = .041), and higher DASH scores (greater limitation) (p &lt; .001). For all participants there was less strength (elbow flexion, wrist flexion, grip), less shoulder ROM, and decreased sensation at the medial upper arm (p &lt; .05) in the affected UE. These differences were greater in women with lymphedema, particularly in shoulder abduction ROM (p &lt; .05). Women with lymphedema had bilaterally less elbow flexion strength and shoulder ROM (p &lt; .05). Past diagnosis of lymphedema, grip strength, shoulder abduction ROM, and number of comorbidities contributed to the variance in DASH scores (R (2) of 0.463, p &lt; .001).Implications for cancer survivorsUE impairments are found in women following treatment for BC. Women with lymphedema have greater UE impairment and limitation in activities than women without. Many of these impairments are amenable to prevention measures or treatment, so early detection by health care providers is essential